Two Sigma Advisers’s NuVasive, Inc. NUVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-677,400
| Closed | -$28.2M | – | 2648 |
|
|
2023
Q2 | $28.2M | Sell |
677,400
-321,700
| -32% | -$13.2M | 0.07% | 252 |
|
|
2023
Q1 | $41.3M | Buy |
999,100
+663,900
| +198% | +$28.4M | 0.11% | 192 |
|
|
2022
Q4 | $13.8M | Buy |
335,200
+233,400
| +229% | +$9.45M | 0.04% | 424 |
|
|
2022
Q3 | $4.46M | Buy |
101,800
+75,800
| +292% | +$3.67M | 0.01% | 786 |
|
|
2022
Q2 | $1.28M | Hold |
26,000
| – | – | ﹤0.01% | 1457 |
|
|
2022
Q1 | $1.47M | Buy |
26,000
+8,800
| +51% | +$467K | ﹤0.01% | 1424 |
|
|
2021
Q4 | $903K | Sell |
17,200
-51,900
| -75% | -$2.82M | ﹤0.01% | 1610 |
|
|
2021
Q3 | $4.14M | Sell |
69,100
-316,800
| -82% | -$19.5M | 0.01% | 886 |
|
|
2021
Q2 | $26.2M | Buy |
385,900
+108,600
| +39% | +$7.41M | 0.07% | 275 |
|
|
2021
Q1 | $18.2M | Sell |
277,300
-148,500
| -35% | -$8.91M | 0.05% | 387 |
|
|
2020
Q4 | $24M | Buy |
425,800
+415,600
| +4,075% | +$20.4M | 0.06% | 300 |
|
|
2020
Q3 | $495K | Sell |
10,200
-8,800
| -46% | -$474K | ﹤0.01% | 1821 |
|
|
2020
Q2 | $1.06M | Sell |
19,000
-3,300
| -15% | -$191K | ﹤0.01% | 1556 |
|
|
2020
Q1 | $1.13M | Buy |
22,300
+7,130
| +47% | +$478K | ﹤0.01% | 1412 |
|
|
2019
Q4 | $1.17M | Buy |
15,170
+9,200
| +154% | +$650K | ﹤0.01% | 1496 |
|
|
2019
Q3 | $378K | Sell |
5,970
-3,000
| -33% | -$188K | ﹤0.01% | 1829 |
|
|
2019
Q2 | $525K | Sell |
8,970
-43,100
| -83% | -$2.54M | ﹤0.01% | 1791 |
|
|
2019
Q1 | $2.96M | Buy |
52,070
+42,700
| +456% | +$2.27M | 0.01% | 1055 |
|
|
2018
Q4 | $464K | Buy |
+9,370
| New | +$564K | ﹤0.01% | 1801 |
|
|
2018
Q2 | – | Sell |
-7,670
| Closed | -$400K | – | 2530 |
|
|
2018
Q1 | $400K | Sell |
7,670
-42,800
| -85% | -$2.17M | ﹤0.01% | 1906 |
|
|
2017
Q4 | $2.95M | Buy |
50,470
+36,000
| +249% | +$2.04M | 0.01% | 1067 |
|
|
2017
Q3 | $803K | Buy |
+14,470
| New | +$958K | ﹤0.01% | 1560 |
|
|
2017
Q2 | – | Sell |
-3,370
| Closed | -$252K | – | 2445 |
|
|
2017
Q1 | $252K | Sell |
3,370
-105,400
| -97% | -$7.65M | ﹤0.01% | 2144 |
|
|
2016
Q4 | $7.33M | Sell |
108,770
-114,000
| -51% | -$7.35M | 0.03% | 572 |
|
|
2016
Q3 | $14.8M | Sell |
222,770
-43,700
| -16% | -$2.78M | 0.06% | 327 |
|
|
2016
Q2 | $15.9M | Buy |
266,470
+99,300
| +59% | +$5.37M | 0.08% | 271 |
|
|
2016
Q1 | $8.13M | Sell |
167,170
-16,300
| -9% | -$740K | 0.05% | 380 |
|
|
2015
Q4 | $9.93M | Sell |
183,470
-27,200
| -13% | -$1.39M | 0.06% | 321 |
|
|
2015
Q3 | $10.2M | Sell |
210,670
-164,549
| -44% | -$8.5M | 0.06% | 327 |
|
|
2015
Q2 | $17.8M | Buy |
375,219
+335,049
| +834% | +$15.7M | 0.13% | 202 |
|
|
2015
Q1 | $1.85M | Sell |
40,170
-13,200
| -25% | -$613K | 0.01% | 810 |
|
|
2014
Q4 | $2.52M | Buy |
53,370
+30,600
| +134% | +$1.28M | 0.02% | 735 |
|
|
2014
Q3 | $794K | Sell |
22,770
-28,400
| -56% | -$1.01M | 0.01% | 1271 |
|
|
2014
Q2 | $1.82M | Sell |
51,170
-17,400
| -25% | -$596K | 0.01% | 862 |
|
|
2014
Q1 | $2.64M | Buy |
68,570
+7,400
| +12% | +$272K | 0.02% | 646 |
|
|
2013
Q4 | $1.98M | Buy |
61,170
+43,700
| +250% | +$1.31M | 0.02% | 746 |
|
|
2013
Q3 | $428K | Sell |
17,470
-76,810
| -81% | -$1.89M | 0.01% | 1475 |
|
|
2013
Q2 | $2.34M | Buy |
+94,280
| New | +$2.06M | 0.03% | 461 |
|
Other funds holding NUVA
Two Sigma Advisers's NUVA Position: Q3 2023 in Review
Two Sigma Advisers sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 677,400 shares — an estimated $28.2M sold.
Two Sigma Advisers first reported a position in NUVA in Q2 2013 and held it in 38 quarters. The position peaked at $41.3M in Q1 2023. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.
- Two Sigma Advisers reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
- Two Sigma Advisers sold 677,400 NuVasive, Inc. shares in Q3 2023, an estimated $28.2M.
- Two Sigma Advisers first reported a position in NuVasive, Inc. in Q2 2013 and held it in 38 quarters.
- Two Sigma Advisers's NuVasive, Inc. position peaked at $41.3M in Q1 2023.
- 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.
Based on Two Sigma Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.